アメリカへのチケットです.

A M Osteen

Lancet (London, England)

|February 25, 1984

まとめ

No abstract available in PubMed .

関連する概念動画

こちらも読む

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え

Same author

CME requirements for Maryland medical license renewal.

Maryland medical journal (Baltimore, Md. : 1985)·1995

Same author

25 years in continuing medical education. The silver anniversary of the AMA PRA.

JAMA·1993

Same author

Continuing medical education. Unabated debate.

JAMA·1992

Same author

Refocusing support and direction.

JAMA·1991

Same author

Continuing medical education.

JAMA·1990

Same author

Continuing medical education.

JAMA·1989

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

関連する実験動画

アメリカへのチケットです.

関連する概念動画

CME requirements for Maryland medical license renewal.

25 years in continuing medical education. The silver anniversary of the AMA PRA.

Continuing medical education. Unabated debate.

Refocusing support and direction.

Continuing medical education.

Continuing medical education.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

関連する実験動画

アメリカへのチケットです.

関連する概念動画

CME requirements for Maryland medical license renewal.

25 years in continuing medical education. The silver anniversary of the AMA PRA.

Continuing medical education. Unabated debate.

Refocusing support and direction.

Continuing medical education.

Continuing medical education.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

関連する実験動画

アメリカへのチケットです.

関連する概念動画

関連記事

CME requirements for Maryland medical license renewal.

25 years in continuing medical education. The silver anniversary of the AMA PRA.

Continuing medical education. Unabated debate.

Refocusing support and direction.

Continuing medical education.

Continuing medical education.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

関連する実験動画

アメリカへのチケットです.

関連する概念動画

関連記事

CME requirements for Maryland medical license renewal.

25 years in continuing medical education. The silver anniversary of the AMA PRA.

Continuing medical education. Unabated debate.

Refocusing support and direction.

Continuing medical education.

Continuing medical education.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.